Format

Send to

Choose Destination
Neurodegener Dis. 2012;10(1-4):257-60. doi: 10.1159/000334285. Epub 2012 Jan 17.

Update on genetics of parkinsonism.

Author information

1
Department of Neurology, Mayo Clinic Florida, Jacksonville, Fla 32224, USA.

Abstract

BACKGROUND:

Major progress in genetic studies of Parkinson's disease (PD) and parkinsonism has been achieved in the last two decades.

OBJECTIVE:

We provide a brief review of the current status of PARK and non-PARK loci/genes, and discuss two new genes: eIF4G1 and VPS35.

METHODS:

The literature on PARK and non-PARK loci/genes was reviewed and some novel information on two new genes is provided.

RESULTS:

There are 18 PARK loci. The symptomatic carriers of these genes usually present with parkinsonism, although additional clinical features can be seen during the course of the disease. Carriers of non-PARK loci/genes frequently present with a mixed phenotype that includes parkinsonism and additional clinical features. Carriers of the eIF4G1 and VPS35 genes present with a parkinsonian phenotype. The pathology of eIF4G1 is of the α-synuclein type; the pathology of VPS35 is unknown.

CONCLUSION:

The current genetic classification of PD/parkinsonism genes is not ideal. The pathological classification based on the accumulation of particular proteins/inclusions is also misleading since there are kindred with a single mutation but pleomorphic pathology. A better classification of neurodegenerative conditions is needed. It is hoped that the genetic studies will lead to better therapies.

PMID:
22261420
PMCID:
PMC3363351
DOI:
10.1159/000334285
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center